Intas BiopharmaceuticalsAsk about thisResearch thisFollow this1 signals · Last mention 9/7/2026Signals mentioning Intas Biopharmaceuticals9/7/2026Tata Capital Healthcare Fund targets ₹2,500 crore, sees IPO-led exits